SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-236205
Filing Date
2023-09-15
Accepted
2023-09-15 16:27:52
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFM14A d548459ddefm14a.htm DEFM14A 2754914
2 GRAPHIC g515332g00a29.jpg GRAPHIC 90410
3 GRAPHIC g515332g00a30.jpg GRAPHIC 107183
4 GRAPHIC g515332g20t72.jpg GRAPHIC 967
5 GRAPHIC g515332snap1.jpg GRAPHIC 2662
6 GRAPHIC g515332snap2.jpg GRAPHIC 1002
7 GRAPHIC g515332snap3.jpg GRAPHIC 1156
8 GRAPHIC g515332snap4.jpg GRAPHIC 1347
  Complete submission text file 0001193125-23-236205.txt   3038924
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-40505 | Film No.: 231259107
SIC: 2836 Biological Products, (No Diagnostic Substances)